Please provide your email address to receive an email when new articles are posted on . The use of preoperative axillary ultrasound and fine-needle aspiration cytology could spare women scheduled to ...

Women with node-negative breast cancers 2 cm or smaller and negative preoperative axillary ultrasound results may be safely spared sentinel lymph node biopsy (SLN) biopsy, new research suggests. SLN ...

Sentinel lymph node biopsy (SLNB) is a standard procedure in the therapeutic management of patients with non-advanced breast cancer. To analyse the utility of ultrasound scan (USS) examination in the ...

The purpose of this study was to examine the use of ultrasound (US)-guided core biopsy of axillary nodes in patients with operable breast cancer. The ipsilateral axillae of 187 patients with suspected ...

This Canadian study included 111 women (median age 63 years), most of whom (90%, n=100) had invasive ductal carcinoma. Over the entire cohort, more than half (54%, n=60) underwent mastectomy and 46% ...

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer Postchemotherapy AUS images were reviewed for 611 patients. One hundred thirty ...

Research into whether ultrasounds to detect breast cancer in underarm lymph nodes are less effective in obese women has produced a surprising finding. Fat didn’t obscure the images — and ultrasounds ...

While ultrasound is usually viewed as more cost effective, MRI is most often used to evaluate the rotator cuff. When performing a cost utility analysis, utilizing an ultrasound as the initial imaging ...

Do all women with lymph node-positive breast cancer treated with neoadjuvant chemotherapy need to have all of their axillary nodes surgically removed? The answer seems to depend on whom you ask. For ...

ASCO has a new guideline update recommending a more limited role for sentinel lymph node biopsy (SLNB) in early-stage breast cancer. According to the recommendation, several types of patients -- ...

Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer The American College of Surgeons Oncology Group Z1071 trial reported a 12.6% ...